EUVIMEDObjevte EUVIMED
Crossref

Stress Tests, Regulatory Costs, and Valuation Discount: Evidence From a Fuzzy Regression Discontinuity Approach

Jianren Xu, Yi Zheng

Financial Review · 2026-08-03

DOI: 10.1111/fire.70072 ↗

At a glance

Journal article in Financial Review, published online on 2026-08-03. Written by Jianren Xu and 1 co-authors. 77 references.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Using a fuzzy regression discontinuity design, we identify a negative causal relationship between stress tests and bank valuation, proxied by Tobin's Q and market‐to‐book ratio. We examine reputational costs and financing costs as measurable regulatory costs contributing to the valuation discount. We also find that the valuation declines induced by any single stress test become more severe as banks participate in more tests. The regulatory costs at both the firm and macroeconomic levels are economically significant. Strong (weak) profitability and robust (poor) ex‐ante capitalization mitigate (aggravate) the negative effects of stress tests, and we quantify such moderating effects. Our study is informative to bank stakeholders and has policy implications.

Cite

APA

Xu, J., & Zheng, Y. (2026). Stress Tests, Regulatory Costs, and Valuation Discount: Evidence From a Fuzzy Regression Discontinuity Approach. Financial Review. https://doi.org/10.1111/fire.70072

Vancouver

Xu J, Zheng Y. Stress Tests, Regulatory Costs, and Valuation Discount: Evidence From a Fuzzy Regression Discontinuity Approach. Financial Review. 2026. doi:10.1111/fire.70072

BibTeX
@article{Xu2026,
  author = {Xu, Jianren and Zheng, Yi},
  title = {Stress Tests, Regulatory Costs, and Valuation Discount: Evidence From a Fuzzy Regression Discontinuity Approach},
  journal = {Financial Review},
  year = {2026},
  doi = {10.1111/fire.70072}
}
Start for free →